EU USA

Zygofix

Industry:
Health
Country:
Israel

Over 1M spinal fusion procedures are performed annually worldwide. Current spinal fusion procedures are highly invasive: they are based on building “screw-bridges”, connected by metal rods stabilizing motion between vertebrae. There are no effective treatments in the market that substitute the current invasive implants.

zLOCK is a small implant that resolves spinal fusion by eliminating the need for screws and rods. zLOCK minimizes the invasiveness of procedures through a percutaneous approach, where only a small skin incision is required for implant placement, making it suitable for outpatient procedures. zLOCK can revolutionize spinal fusion standard clinical practice and the market. The implant value propositions have been confirmed in a first-in-human trial. With the EIC Accelerator project, ZygoFix will complete the necessary upgrades and clinical validation activities, achieve CE-marking, and accelerate the time-to-market of zLOCK.

Where is your business interest?
USA EUROPE